Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.7004
-0.0282 (-3.87%)
At close: Oct 8, 2026, 4:00 PM EDT
0.7051
+0.0047 (0.67%)
After-hours: Oct 8, 2026, 7:50 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $206.45 million as of October 8, 2026. It is the 20,504th most valuable company in the world and the 3,563rd biggest in the United States. Its market cap has decreased by 40.93% in one year.
Market Cap
206.45M
Enterprise Value
54.76M
1-Year Change
-40.93%
Global Rank
Country Rank
#3,563 United States
Category
ChartMarket Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $206.45M, a decrease of -90.89%. That is a compound annual growth rate of -37.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 206.45M | -69.84% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vogenx | 254.76M |
| Palisade Bio | 254.44M |
| Camp4 Therapeutics | 251.64M |
| Sutro Biopharma | 250.87M |
| Vicore Pharma Holding AB | 249.21M |
| Q32 Bio | 249.17M |
| Greenwich LifeSciences | 248.21M |
| InflaRx | 247.58M |